Related Experiment Video
Updated: May 7, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice
Tianli Wang1, Kyle Baron, Wei Zhong
1Department of Pharmaceutics, University of Minnesota, 308 Harvard St. SE, Minneapolis, Minnesota, 55455, USA.
Purpose:
The current study presents a Bayesian approach to non-compartmental analysis (NCA), which provides the accurate and precise estimate of AUC 0 (∞) and any AUC 0 (∞) -based NCA parameter or derivation.
Methods:
In order to assess the performance of the proposed method, 1,000 simulated datasets were generated in different scenarios. A Bayesian method was used to estimate the tissue and plasma AUC 0 (∞) s and the tissue-to-plasma AUC 0 (∞) ratio. The posterior medians and the coverage of 95% credible intervals for the true parameter values were examined. The method was applied to laboratory data from a mice brain distribution study with serial sacrifice design for illustration.
Results:
Bayesian NCA approach is accurate and precise in point estimation of the AUC 0 (∞) and the partition coefficient under a serial sacrifice design. It also provides a consistently good variance estimate, even considering the variability of the data and the physiological structure of the pharmacokinetic model. The application in the case study obtained a physiologically reasonable posterior distribution of AUC, with a posterior median close to the value estimated by classic Bailer-type methods.
Conclusions:
This Bayesian NCA approach for sparse data analysis provides statistical inference on the variability of AUC 0 (∞) -based parameters such as partition coefficient and drug targeting index, so that the comparison of these parameters following destructive sampling becomes statistically feasible.
Related Concept Videos
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioequivalence Data: Statistical Interpretation
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Measurement of Bioavailability: Pharmacokinetic Methods
Dosage Regimens: Partial Pharmacokinetic Parameters
Bioavailability Study Design: Absolute Versus Relative Bioavailability
